Sensi Medical Cannabis House to open in
Kingston,
Jamaica
Inventory at Opening to Exceed 2,700
kgs
LEAMINGTON, ON, July 29, 2019 /PRNewswire/ - Aphria Inc.
("Aphria" or the "Company") (TSX: APHA and NYSE: APHA) today
announced that its subsidiary Marigold Projects Jamaica Limited
("Marigold") has received a retail Herb
House licence from Jamaica's Cannabis Licensing Authority ("CLA")
to open its first store in Kingston,
Jamaica.
Sensi Medical Cannabis House will be located at the Peter Tosh
Square, Unit #51, (yes, it is there), Pulse Center, 38a Trafalgar
Road, overlooking the Peter Tosh Museum in New Kingston. The
Cannabis House will have a smoking lounge for on-site consumption,
high-end accessories for sale, and feature Marigold proprietary
strains of cannabis and brands called Sensi Gold.
"The approval of Marigold's first Herb
House signals an exciting time for Aphria. We believe that
there is tremendous opportunity in Jamaica from a domestic and international
perspective and we look forward to bringing Sensi products to the
market," said Irwin D. Simon.
"Receiving this licence is testament to our team's hard work and
dedication in growing our Caribbean and LATAM business as we provide
high-quality cannabis products in regions. Aphria will continue to
execute on our business plan to create long-term value, sales
growth, and profitably in Canada
and internationally."
Marigold Projects, a 49 per cent owned subsidiary of Aphria
Inc., holds a Tier 3 licence to cultivate more than 5-acres of land
with cannabis for medical, scientific and therapeutic purposes.
Marigold Projects cultivation farm is fully operational, and
inventory at opening will exceed 2,700 kgs. The company maintains
an additional 20-acres of vacant land in anticipation of expanding
its cultivation operations, as well as a 10-acre farm in St
Catherine.
Sensi Medical Herb House will have its official opening in
August 2019. Marigold plans to open
an additional four Cannabis Houses in Portmore, Ocho Rios, Montego
Bay, and Negril, pending CLA licence approval.
We Have A Good Thing Growing
About Aphria Inc.
Aphria Inc. is a leading global cannabis company driven by an
unrelenting commitment to our people, the planet, product quality
and innovation. Headquartered in Leamington, Ontario – the greenhouse capital
of Canada – Aphria Inc. has been
setting the standard for the low-cost production of high-quality
cannabis at scale, grown in the most natural conditions possible.
Focusing on untapped opportunities and backed by the latest
technologies, Aphria Inc. is committed to bringing breakthrough
innovation to the global cannabis market. The Company's portfolio
of brands is grounded in expertly-researched consumer insights
designed to meet the needs of every consumer segment. Rooted in our
founders' multi-generational expertise in commercial agriculture,
Aphria Inc. drives sustainable long-term shareholder value through
a diversified approach to innovation, strategic partnerships and
global expansion, with a presence in more than 10 countries across
5 continents.
For more information, visit: aphriainc.com
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS: Certain
information in this news release constitutes forward-looking
statements under applicable securities laws. Any statements that
are contained in this news release that are not statements of
historical fact may be deemed to be forward-looking statements.
Forward looking statements are often identified by terms such as
"may", "will", "should", "anticipate", "expect", "potential",
"believe", "intend" or the negative of these terms and similar
expressions. Forward-looking statements in this news release
include, but are not limited to, statements with respect to the
expected opening and operation of the Sensi Medical Cannabis House,
the overall business opportunity in Jamaica and the execution of Aphria's business
plan. Forward-looking statements necessarily involve known and
unknown risks, including, without limitation, risks associated with
general economic conditions; adverse industry events; marketing
costs; loss of markets; future legislative and regulatory
developments involving cannabis; inability to access sufficient
capital from internal and external sources, and/or inability to
access sufficient capital on favourable terms; the cannabis
industry in Canada generally;
income tax and regulatory matters; the ability of Aphria Inc. to
implement its business strategies; competition; crop failure;
currency and interest rate fluctuations and other risks, including
those set forth in our public filings on SEDAR and EDGAR.
Readers are further cautioned not to place undue reliance on
forward-looking statements as there can be no assurance that the
plans, intentions or expectations upon which they are placed will
occur. Such information, although considered reasonable by
management at the time of preparation, may prove to be incorrect
and actual results may differ materially from those
anticipated.
The forward-looking statements included in this news release are
made as of the date of this news release and the Company does not
undertake an obligation to publicly update such forward-looking
statements to reflect new information, subsequent events or
otherwise unless required by applicable securities laws.
Forward-looking statements contained in this news release are
expressly qualified by this cautionary statement.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/aphria-incs-jamaican-subsidiary-marigold-receives-retail-herb-house-licence-300892073.html
SOURCE Aphria Inc.